Brief: Charles River Laboratories Announces Chief Financial Officer Transition
Sept 16 (Reuters) - Charles River Laboratories International Inc CRL.N: CHARLES RIVER LABORATORIES ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION MICHAEL G. KNELL APPOINTED INTERIM CFO OF CHARLES RIVER LABORATORIES REAFFIRMS 2025 REVENUE AND NON-GAAP EPS GUIDANCE FLAVIA H. PEASE RESIGNS AS CFO OF CHARLES RIVER LABORATORIES FY2025 EARNINGS PER SHARE VIEW $10.20, REVENUE VIEW $3.99 BILLION -- LSEG IBES DATA Source text: ID:nBw94Wpnta Further company coverage: CRL.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charles River Laboratories International
See all newsBrief: Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
European life sciences stocks rise on strong sector momentum